Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides (original) (raw)

New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis

Cees Kallenberg

Autoimmunity Reviews, 2002

View PDFchevron_right

Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

Shaun Andrew

Clinical & Experimental Immunology, 2011

View PDFchevron_right

Immunopathogenesis of ANCA-Associated Vasculitis

kalthoum Tizaoui

International Journal of Molecular Sciences, 2020

View PDFchevron_right

Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides

Russell Buchanan

Rheumatology International, 1996

View PDFchevron_right

The immunopathology of ANCA-associated vasculitis

Eoin McKinney

2014

View PDFchevron_right

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis

Jan Willem Cohen Tervaert

Kidney International, 2000

View PDFchevron_right

Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides

Wayel Abdulahad

Autoimmunity reviews, 2018

View PDFchevron_right

C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis

Ulf Persson

Clinical and Experimental Immunology, 1999

View PDFchevron_right

New pathophysiological insights and treatment of ANCA-associated vasculitis

Jan Willem Cohen Tervaert

Kidney International, 2011

View PDFchevron_right

Immune regulatory mechanisms in ANCA-associated vasculitides

Wayel Abdulahad

Autoimmunity Reviews, 2000

View PDFchevron_right

Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies

Fionnuala Hickey

Scientific Reports, 2015

View PDFchevron_right

Antineutrophil cytoplasmic antibodies (ANCA): Role in disease pathogenesis, diagnosis, and monitoring ANCA associated vasculitis

Gilda SANDRI

Indian Journal of Rheumatology, 2015

View PDFchevron_right

Autoantibodies in systemic vasculitis

Jan Willem Cohen Tervaert

Australian and New Zealand Journal of Medicine, 1991

View PDFchevron_right

Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System

Bahjat al-Ani

PLoS ONE, 2012

View PDFchevron_right

Pathogenesis and biomarkers in ANCA-associated vasculitis

Vessel Plus

Vessel Plus, 2021

View PDFchevron_right

Type of ANCA may be Superior to Clinical Phenotype in Distinguishing Different Clinical Entities in ANCA-associated Vasculitis

Maria Stangou

View PDFchevron_right

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis

Maria Stangou

Life

View PDFchevron_right

Pathophysiology of ANCA-associated small vessel vasculitis

Cees Kallenberg

Current rheumatology reports, 2010

View PDFchevron_right

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

Cees Kallenberg

Annals of the Rheumatic Diseases, 2008

View PDFchevron_right

Targeting B Lymphocytes as Therapy for ANCA-Associated Vasculitis

Ulrich Specks

Rheumatic Disease Clinics of North America, 2007

View PDFchevron_right

Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides

Cees Kallenberg

Nature Clinical Practice Rheumatology, 2006

View PDFchevron_right

A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions

G. Cambridge

Clinical and Experimental Immunology, 1999

View PDFchevron_right

Pathophysiology of ANCA-associated vasculitides: Are ANCA really pathogenic?

jan willem cohen tervaert

Kidney International, 2004

View PDFchevron_right

Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides

Cees Kallenberg

Nephrology Dialysis Transplantation, 2009

View PDFchevron_right

Key advances in the clinical approach to ANCA-associated vasculitis

Cees Kallenberg

Nature reviews. Rheumatology, 2014

View PDFchevron_right

Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

Yichun Hu

Arthritis & Rheumatism, 2012

View PDFchevron_right

Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis

Cees Kallenberg

Kidney International, 1998

View PDFchevron_right

Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

Richard Watts

Clinical Journal of the American Society of Nephrology, 2008

View PDFchevron_right

Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission

Sophie Ohlsson

Clinical and Experimental Immunology, 2003

View PDFchevron_right

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Glimpse into The Future

Hannah Naquib

Journal of Advanced Zoology

View PDFchevron_right

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Zdenka Hruskova

New England Journal of Medicine, 2012

View PDFchevron_right

Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood

Giacomo Simonetti

Pediatric Nephrology, 2010

View PDFchevron_right

Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known

Emile Heer

Clinical Journal of the American Society of Nephrology, 2008

View PDFchevron_right